Pfizer’s Big Bet On Arena Pays Off With First Phase III Win For Etrasimod In UC
Top-Line Readout Follows Recent $6.7bn Acquisition
The company will present detailed data in the future, but top-line results show statistically significant improvement over placebo at 12 weeks in ulcerative colitis, an increasingly competitive market.
